LY75 and cutaneous melanoma: As shown in Figure 1 and Figure 2, Ly75 expression was significantly downregulated in skin cutaneous melanoma (SKCM), and its expression was positively correlated with the survival rates of patients with SKCM in multiple datasets (Figure 2 and Figure 3c), implicating that the downregulated expression of Ly75 affects melanoma malignancy.